Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project
Cureus · 11.09.2023
DOI: 10.7759/cureus.45024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 11.09.2023. Verfasst von Dae Hyun Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, University of South Florida, Tampa, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transthyretin cardiac amyloidosis (ATTR) is an important comorbidity present in severe aortic stenosis (AS). The purpose of this study was to raise awareness of ATTR in patients who underwent transcatheter aortic valve replacement (TAVR) for severe AS among healthcare providers and patients. Methodology We reviewed 197 consecutive TAVR cases performed from 2019 to 2020. Adapting predefined high-risk features for ATTR based on prior literature, we contacted the patients to discuss our clinical suspicion of ATTR and offered a referral to a cardiac amyloid specialist.
Results
We identified 125 (69.4%) patients who had high-risk features of ATTR. Of the 105 patients contacted, 44 patients agreed to referral, 46 patients were not able to be contacted after several attempts, and 15 patients declined referral. Of the 44 patients who agreed to the referral, 20 patients completed the evaluation for cardiac amyloidosis, all of whom were negative for transthyretin and light-chain cardiac amyloidosis.
Conclusions
Our attempt to detect ATTR in prior TAVR patients was unsuccessful two to three years post-TAVR. We believe that early detection of cardiac amyloidosis close to the timing of TAVR is important and the most effective means.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, University of South Florida, Tampa, USA.
- Department of Internal Medicine, University of South Florida, Tampa, USA.
Zitieren
APA
Lee, D. H., Eichelberger, G. S., Patel, V., Chhaya, R., Khadilkar, A., Bishop, J., Bezerra, H., Oliveira, G., Matar, F., & Fernandez, J. (2023). Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project. Cureus. https://doi.org/10.7759/cureus.45024
Vancouver
Lee DH, Eichelberger GS, Patel V, Chhaya R, Khadilkar A, Bishop J, et al. Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project. Cureus. 2023. doi:10.7759/cureus.45024
BibTeX
@article{Lee2023,
author = {Lee, Dae Hyun and Eichelberger, Gerry S and Patel, Vandan and Chhaya, Ronak and Khadilkar, Arjun and Bishop, Jennifer and Bezerra, Hiram and Oliveira, Guilherme and Matar, Fadi and Fernandez, Joel},
title = {Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.45024}
}
EUVIMED